Skip to main content
Table of Contents
Print

Do Psychiatrists Support Cannabis as Adjunct Mood Therapy? 

Author: Dr. Clarissa Morton, PharmD

The question of psychiatrists’ cannabis opinions is an important one for patients considering cannabis alongside conventional treatment for depression or bipolar disorder. While some mental health professionals see potential benefits, others remain cautious, citing a lack of robust long-term evidence. For individuals with mood disorders, this means psychiatric support for cannabis as an adjunct therapy varies widely. Patients with a mental health condition may find that acceptance depends on the psychiatrist’s personal perspective and the severity of their symptoms. 

Some clinicians acknowledge that CBD, in particular, may have fewer risks and could complement therapy. However, concerns remain about THC’s potential to destabilise mood or increase anxiety in vulnerable patients. 

Psychiatric Perspectives on Cannabis 

Exploring psychiatrists’ cannabis opinions sheds light on how clinicians approach cannabis in mood care. 

Clinician Views on Cannabis 

Current clinician views on cannabis reveal a cautious but growing openness, especially where standard treatments have failed or caused intolerable side effects. 

Psychiatric Attitudes Cannabis 

Most psychiatric attitudes towards cannabis emphasise that while anecdotal reports are positive, strong clinical trials are still lacking to support widespread adoption. 

Adjunct Therapy Cannabis 

Some psychiatrists see potential in adjunct therapy with cannabis, particularly in CBD-dominant forms, but stress that it should never replace established medications or structured therapy. 

In summary, while psychiatrists’ cannabis opinions are shifting, there is no universal endorsement yet. Ongoing research and careful, supervised use remain essential for safe integration into mood disorder care. 

For patients curious about professional views on cannabis, providers like LeafEase can offer supportive consultations to bridge the gap between research and lived experience. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Mood Disorders.

Dr. Clarissa Morton, PharmD
Author

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Categories